In this study, we evaluated the genomic alterations of GATA3 in breast tumors, using the data collected by TCGA18, and analyzed the associations of GATA3 somatic mutations with tumor features, patient survival, and tumor gene expression profiles to highlight the clinical importance of this gene in breast cancer. This evidence concerns the gene GATA3 and breast cancer.